Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials

Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0110022. doi: 10.1128/aac.01100-22. Epub 2022 Sep 12.
No abstract available

Keywords: CRE; Enterobacterales; OXA-48; beta-lactamases; cefiderocol.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Cefiderocol
  • Cephalosporins* / pharmacology
  • Cephalosporins* / therapeutic use
  • Microbial Sensitivity Tests
  • beta-Lactamases* / genetics

Substances

  • Cephalosporins
  • beta-Lactamases
  • Anti-Bacterial Agents